Omnicell Future Growth
Future criteria checks 0/6
Omnicell's earnings are forecast to decline at 29.9% per annum while its annual revenue is expected to grow at 3.1% per year. EPS is expected to decline by 37.7% per annum. Return on equity is forecast to be 5.7% in 3 years.
Key information
-29.9%
Earnings growth rate
-37.71%
EPS growth rate
| Medical Equipment earnings growth | 12.5% |
| Revenue growth rate | 3.1% |
| Future return on equity | 5.66% |
| Analyst coverage | Good |
| Last updated | 23 May 2025 |
Recent future growth updates
US$38.50: That's What Analysts Think Omnicell, Inc. (NASDAQ:OMCL) Is Worth After Its Latest Results
May 09
Results: Omnicell, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 09Recent updates
Near-shoring And Digitization Will Drive Stability Despite Tariff Challenges
Supply chain improvements and near-shoring are expected to offset cost pressures, while a shift to recurring SaaS and services enhances earnings stability and valuation potential.It Looks Like Omnicell, Inc.'s (NASDAQ:OMCL) CEO May Expect Their Salary To Be Put Under The Microscope
May 14US$38.50: That's What Analysts Think Omnicell, Inc. (NASDAQ:OMCL) Is Worth After Its Latest Results
May 09Omnicell: Facing New Headwinds
May 07Omnicell (NASDAQ:OMCL) Seems To Use Debt Rather Sparingly
Apr 07Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?
Mar 20Why Omnicell's (NASDAQ:OMCL) Earnings Are Better Than They Seem
Feb 14Omnicell Q4 Earnings: Ignore The Short-Term Noise
Feb 12Results: Omnicell, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 09Omnicell, Inc. (NASDAQ:OMCL) Shares Could Be 26% Below Their Intrinsic Value Estimate
Jan 28Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues
Nov 27Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next
Nov 02Omnicell Q3 Earnings: Look At The Growth Segment
Nov 01Is It Time To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?
Oct 31Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?
Oct 07Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%
Aug 02Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?
Jul 11Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Jun 16Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt
May 25An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued
Mar 28Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues
Feb 29Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?
Feb 23Omnicell Is Building A Strong Moat
Feb 22Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?
Jan 15Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Dec 25Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?
Dec 06Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%
Nov 10Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?
Sep 06Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?
Aug 08Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching
Jul 02A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)
Jun 08Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital
Apr 29Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?
Apr 11At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?
Mar 23Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 1,237 | 14 | 67 | 136 | 4 |
| 12/31/2026 | 1,175 | 8 | 59 | 125 | 8 |
| 12/31/2025 | 1,132 | -5 | 9 | 119 | 8 |
| 3/31/2025 | 1,136 | 21 | 108 | 164 | N/A |
| 12/31/2024 | 1,112 | 13 | 135 | 188 | N/A |
| 9/30/2024 | 1,064 | -18 | 118 | 170 | N/A |
| 6/30/2024 | 1,080 | -21 | 152 | 204 | N/A |
| 3/31/2024 | 1,103 | -21 | 165 | 218 | N/A |
| 12/31/2023 | 1,147 | -20 | 126 | 181 | N/A |
| 9/30/2023 | 1,186 | -34 | 165 | 225 | N/A |
| 6/30/2023 | 1,235 | -23 | 127 | 189 | N/A |
| 3/31/2023 | 1,268 | -18 | 48 | 107 | N/A |
| 12/31/2022 | 1,296 | 6 | 17 | 78 | N/A |
| 9/30/2022 | 1,309 | 48 | -5 | 55 | N/A |
| 6/30/2022 | 1,258 | 61 | 18 | 77 | N/A |
| 3/31/2022 | 1,199 | 72 | 98 | 158 | N/A |
| 12/31/2021 | 1,132 | 78 | 173 | 232 | N/A |
| 9/30/2021 | 1,070 | 80 | 195 | 249 | N/A |
| 6/30/2021 | 987 | 60 | 194 | 242 | N/A |
| 3/31/2021 | 914 | 35 | 164 | 218 | N/A |
| 12/31/2020 | 892 | 32 | 131 | 186 | N/A |
| 9/30/2020 | 891 | 38 | 86 | 144 | N/A |
| 6/30/2020 | 906 | 49 | 101 | 164 | N/A |
| 3/31/2020 | 924 | 69 | 85 | 144 | N/A |
| 12/31/2019 | 897 | 61 | 83 | 145 | N/A |
| 9/30/2019 | 860 | 54 | 98 | 158 | N/A |
| 6/30/2019 | 836 | 48 | 59 | 117 | N/A |
| 3/31/2019 | 807 | 38 | 55 | 112 | N/A |
| 12/31/2018 | 787 | 38 | N/A | 104 | N/A |
| 9/30/2018 | 772 | 54 | N/A | 61 | N/A |
| 6/30/2018 | 754 | 48 | N/A | 27 | N/A |
| 3/31/2018 | 747 | 44 | N/A | 16 | N/A |
| 12/31/2017 | 713 | 31 | N/A | 25 | N/A |
| 9/30/2017 | 688 | -1 | N/A | 45 | N/A |
| 6/30/2017 | 678 | -6 | N/A | 72 | N/A |
| 3/31/2017 | 670 | -9 | N/A | 56 | N/A |
| 12/31/2016 | 696 | 10 | N/A | 50 | N/A |
| 9/30/2016 | 651 | 8 | N/A | 54 | N/A |
| 6/30/2016 | 599 | 14 | N/A | 40 | N/A |
| 3/31/2016 | 539 | 24 | N/A | 44 | N/A |
| 12/31/2015 | 485 | 31 | N/A | 38 | N/A |
| 9/30/2015 | 476 | 32 | N/A | 37 | N/A |
| 6/30/2015 | 463 | 32 | N/A | 50 | N/A |
| 3/31/2015 | 455 | 31 | N/A | 75 | N/A |
| 12/31/2014 | 441 | 31 | N/A | 65 | N/A |
| 9/30/2014 | 425 | 28 | N/A | 49 | N/A |
| 6/30/2014 | 407 | 29 | N/A | 59 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OMCL's earnings are forecast to decline over the next 3 years (-29.9% per year).
Earnings vs Market: OMCL's earnings are forecast to decline over the next 3 years (-29.9% per year).
High Growth Earnings: OMCL's earnings are forecast to decline over the next 3 years.
Revenue vs Market: OMCL's revenue (3.1% per year) is forecast to grow slower than the US market (8.6% per year).
High Growth Revenue: OMCL's revenue (3.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OMCL's Return on Equity is forecast to be low in 3 years time (5.7%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/30 07:16 |
| End of Day Share Price | 2025/05/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Omnicell, Inc. is covered by 26 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| K. Juhng | BB&T Capital Markets |
| William Sutherland | Benchmark Company |
| Raymond Myers | Benchmark Company |